Refine your search

Annakaisa Haapasalo Group (Molecular Neurodegeneration)´s Profile image

Annakaisa Haapasalo Group (Molecular Neurodegeneration)

Research group
01.06.2015 -
A.I. Virtanen Institute for Molecular Sciences, Faculty of Health Sciences

Leaders

Our group studies the molecular mechanisms of neurodegeneration involved in the pathogenesis of neurodegenerative disorders (NDDs), including genetic and non-genetic (sporadic) frontotemporal dementia (FTD), the most common cause of dementia in under 60-year-olds. We especially focus on the genetic form of FTD caused by the hexanucleotide repeat expansion in the C9orf72 gene, because it is exceptionally common in Finnish FTD patients. In our collaborative projects, we are also interested in other NDDs, such as Alzheimer’s disease and dementia with Lewy bodies. We examine altered interactions and molecular pathogenetic and functional changes in neurons and glial cells derived from patients having these diseases. We also aim to identify novel diagnostic and predictive biomarkers and therapeutic options in NDDs.

Our research group comprises experts in different fields. Our researchers’ expertise lies in patient-derived induced pluripotent stem cell (iPSC)-based disease models, different cell and molecular biological methods, fluorescence and confocal microscopy-based imaging, biochemical techniques, gene editing technology, and measuring different biological and electrophysiological responses of different brain cells as well as investigating alterations in gene expression.

We are active participants in the Finnish FTD Research Network, FinFTD, and we closely collaborate with clinical researchers who specialize in NDDs with the goal of translating our findings for the benefit of the patients. We are coordinating the EU JPND and Research Council of Finland -funded SynaDeg project (Pre-diagnostic early synaptic disturbances in neurodegenerative diseases) and are partners in two Horizon EU projects: PREDICTFTD (Accelerating the Validation of Predictive Liquid Biomarkers for Frontotemporal Dementia Diagnosis and Subclassification) ja SYNAPSING (Synapsing Mental Disorders and Neurodegenerative diseases: Towards more effective diagnosis and management of psychiatric symptoms). We also have several ongoing projects funded by different foundations.

News

Projects

Cooperation

Molecular Neurodegeneration Group 10-year anniversary dinner 2025

Molecular Neurodegeneration Group 10-year anniversary dinner 2025

Publications

28 items